Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging study

Overview of attention for article published in Respiratory Research, May 2013

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,003 followers.

Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and… http://t.co/mRiPCr05gT

GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma http://t.co/9tzJqCSkbJ

#respiratoryresearch Efficacy, safety & tolerability of GSK2190915..in adults and adolescents with persistent asthma http://t.co/tYbK1elPCM

#respiratoryresearch Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase… http://t.co/Tl6Tg2QZi7

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.